I’ve got a piece coming up today at The Atlantic Monthly’s business site on the state of the biotech industry out in the Bay Area. Since the Genentech takeover fight broke out, a persistent theme in the comments here (and…
So many people up here think that Seattle is alone in its misery, that the other biotech regions are doing great. This short article begs to differ.
I’d still say they are doing better than we are but I think we have some things that give us an advantage, if properly nurtured.